Awards and Recognitions Dr. Neeloufar Fakourfar was recognized through a CSHP Spotlight this month with an article highlighting her pharmacy journey. Dr. Amy Kang was invited as a guest speaker on the Duke University Antimicrobial Stewardship Outreach Network podcast to discuss her recent publication: “Assessment of Antimicrobial Transition Errors From Hospitals to Skilled Nursing Facilities.”
Participating in academic pharmacy conferences provides Pharm.D. students with impactful opportunities to explore research, network with professionals, and build their careers while completing coursework and rotations. Chapman University School of Pharmacy (CUSP) prepares our students for these opportunities through practice presentations, faculty mentorship, and conference funding. Building Community Through Pharmacy Conferences For CUSP student Harvey
Kamaljit Kaur, Ph.D., Associate Professor in Biomedical and Pharmaceutical Sciences at Chapman University School of Pharmacy, has received a $535,000 National Cancer Institute (NCI) R15 award from the National Institutes of Health (NIH). Working alongside colleagues Shiuan Chen, Ph.D., of City of Hope, and Chapman University faculty member Surya Nauli, Ph.D., Kaur will lead research
Awards and Recognitions Dr. Emmanuelle Schwartzman received the A. Wayne Pittman Outstanding Service Award from the National Rho Chi Society at the Annual Meeting on March 21, 2026. This is one of the highest awards given by the Society with Dr. Schwartzman being the 2nd recipient of the award. The award recognizes individuals who have
Jerika Lam, Pharm.D., in collaboration with fellow CUSP faculty Enrique Seoane-Vazquez, Ph.D., has received a grant from Gilead Sciences in the amount of $195,430 for her research proposal “Evaluating the effectiveness of implementing lenacapavir as PrEP in underserved populations at a Federally Qualified Health Center.” Pre-exposure prophylaxis (PrEP) drugs are highly effective to prevent individuals
Awards and Recognitions Dr. Amy Kang has been selected to serve as an author panelist for the Infectious Diseases Society of America’s guidance paper on resource framework and staffing for hospital antimicrobial stewardship programs. Dr. Rachita Sumbria was awarded 2025 BPS Paper of the Year for her publication “Hepatic LRP-1 plays an important role in
The National Cancer Institute (NCI) has awarded a $415,500 Academic Research Enhancement Award (R15) to Keykavous Parang, Pharm.D., Ph.D., and Sun “Coco” Yang, Ph.D., to support their innovative cancer research at Chapman University. The project develops next-generation peptide-drug conjugates (PDCs) designed to improve the safety and effectiveness of doxorubicin (DOX), a chemotherapy drug commonly used
Sun “Coco” Yang, Ph.D., has been awarded a $3 million 5-year R01 from the National Institutes of Health as Principal Investigator to advance care for melanoma, an aggressive form of skin cancer. Yang, Associate Professor in the Department of Pharmacy Practice, is a clinical scientist with dual expertise in clinical pharmacy and basic research. In
The Center for Targeted Drug Delivery (CTDD) is our latest research center, created to advance precision drug delivery technologies and translate novel technologies into impactful therapies. The CTDD provides a formal structure that will deepen interdisciplinary collaborations among faculty researchers, industry partners, and other leading research institutions, while also attracting new partnerships. By uniting researchers
Enrique Seoane-Vazquez, Ph.D., has been awarded a two-year, multi–Principal Investigator grant for his project, “Advanced Therapy Medicinal Products: Clinical and Patient-Centered Outcomes.” The project will conduct the most comprehensive evaluation to date of Advanced Therapy Medicinal Products (ATMPs) between 2010 and 2025, and is funded by Arnold Ventures. The study will assess: Safety, efficacy, and